Androgen-Induced Differentiation and Tumorigenicity of Human Prostate Epithelial Cells
Open Access
- 15 December 2004
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 64 (24) , 8867-8875
- https://doi.org/10.1158/0008-5472.can-04-2938
Abstract
Androgen ablation is the primary treatment modality for patients with metastatic prostate cancer; however, the role of androgen receptor signaling in prostate cancer development remains enigmatic. Using a series of genetically defined immortalized and tumorigenic human prostate epithelial cells, we found that introduction of the androgen receptor induced differentiation of transformed prostate epithelial cells to a luminal phenotype reminiscent of organ-confined prostate cancer when placed in the prostate microenvironment. Moreover, androgen receptor expression converted previously androgen-independent, tumorigenic prostate epithelial cells into cells dependent on testosterone for tumor formation. These observations indicate that androgen receptor expression is oncogenic and addictive for the human prostate epithelium.Keywords
All Related Versions
This publication has 52 references indexed in Scilit:
- Molecular determinants of resistance to antiandrogen therapyNature Medicine, 2003
- Role of the stromal microenvironment in carcinogenesis of the prostateInternational Journal of Cancer, 2003
- PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetesNature Genetics, 2003
- Intermediate basal cells of the prostate: In vitro and in vivo characterizationThe Prostate, 2003
- Role of stroma in carcinogenesis of the prostateDifferentiation, 2002
- Autochthonous mouse models for prostate cancer: past, present and futureSeminars in Cancer Biology, 2001
- Infrequent RAS oncogene mutations in human prostate cancerThe Prostate, 1992
- Establishment of a SV40-transformed cell line from primary culture of rat dorsolateral prostatic epithelial cellsExperimental Cell Research, 1990
- A Controlled Trial of Leuprolide with and without Flutamide in Prostatic CarcinomaNew England Journal of Medicine, 1989